Compare Gap Inc (GAP) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gap Inc vs IDEXX Laboratories, Inc. — how do they compare? Gap Inc trades at $23.23 (market cap $8.21B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 4.9× Gap Inc's market cap, and Gap Inc pays a 3% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gap Inc for 37 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| GAP | IDXX | |
|---|---|---|
Market Cap | $8.21B | $40.43B |
Volume | 5,192,917 | 692,164 |
Sector | Consumer Cyclical | Health |
52-Week High | $29.13 | $766.68 |
52-Week Low | $18.35 | $504.70 |
Typical Hold Time | 37 Days | 46 Days |
Enterprise Value | $11.44B | $41.32B |
Dividend Yield | 3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gap Inc. (GAP) trades at $23.36, down 1.06% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $25.67. The company shows improving fundamentals, with net income rising to $844 million in 2025 and a profit margin of 5.59%, supported by recent ventures into music partnerships and brand engagement initiatives.
The outlook for Gap is cautiously optimistic, with valuation metrics like a P/E of 7.04 and P/S of 0.58 suggesting potential upside. Risks include competitive pressures and reliance on brand momentum, but strong cash flow and analyst buy ratings indicate a favorable risk-reward profile for value-oriented investors.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
